Skip to main content
Erschienen in: European Archives of Oto-Rhino-Laryngology 11/2016

31.03.2016 | Otology

Mean platelet volume, red cell distribution width, platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios in patients with ankylosing spondylitis and their relationships with high-frequency hearing thresholds

verfasst von: Nazim Bozan, Mahmut Alpaycı, Mehmet Aslan, Hakan Cankaya, Ahmet Faruk Kıroglu, Mahfuz Turan, Abdurrahman Ayral, Emre Senkoy, Server Ilter

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 11/2016

Einloggen, um Zugang zu erhalten

Abstract

The mean platelet volume (MPV), red cell distribution width (RDW) and neutrophil-to-lymphocyte ratio (NLR) comprise laboratory markers in ankylosing spondylitis (AS). There is a controversy in the literature regarding which type of ear involvement is characteristic of AS. The aim of this study was to simultaneously investigate the MPV, RDW, platelet to lymphocyte (PLR) and NLR in patients with AS and their relationships with high-frequency hearing thresholds. Thirty patients with AS and 35 age-matched healthy subjects were included. Each subject was tested with low- (250, 500, 1000 and 2000 Hz) and high- (4000, 8000, 10,000, 12,000, 14,000 and 16,000 Hz) frequency audiometry. Additionally, the case and control groups were evaluated regarding the average hearing thresholds in bone conduction. The erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels were measured. The RDW, MPV, neutrophils, lymphocytes and platelet counts were evaluated with the complete blood count. Furthermore, the NLR and PLR were calculated. The complete blood count, platelet numbers, ESR, CRP and NLR levels were significantly increased in the AS patients compared with the healthy controls (p < 0.001, p = 0.007, p < 0.001, p < 0.001 and p = 0.047, respectively). There was no statistically significant difference in the RDW, PLR or MPV levels (p > 0.05) in the AS patients compared with the healthy controls. The BASDAI score and disease duration were not correlated with the ESR, CRP levels, MPV, PLR, RDW or NLR in patients with AS (all; p > 0.05). The AS patients had increased average measurement values for the hearing threshold in both ears at frequencies of 250, 500, 1000 and 2000 Hz; however, there was no statistically significant difference (p > 0.05). The average values of the hearing threshold in both ears at the high frequencies of 4000, 6000, 8000, 10,000, 12,000 and 14,000 Hz were significantly increased in the case group; however, it was not significantly increased at 16,000 Hz. The current study is the first to investigate the PLR, NLR, MPV and RDW levels in acute AS. We identified a significantly increased NLR, leukocyte count, ESR and CRP in AS patients. Sensorineural hearing loss, especially at extended high frequencies, is common in patients with AS and may represent an extra-articular feature of the disease. The combined use of NLR with the leukocyte count and other clinical assessments may facilitate the diagnostic process of ankylosing spondylitis.
Literatur
1.
Zurück zum Zitat Zochling J, Smith EU (2010) Seronegative spondyloarthritis. Best Pract Res Clin Rheumatol 24(6):747–756CrossRefPubMed Zochling J, Smith EU (2010) Seronegative spondyloarthritis. Best Pract Res Clin Rheumatol 24(6):747–756CrossRefPubMed
2.
Zurück zum Zitat Ruof J, Stucki G (1999) Validity aspects of erythrocyte sedimentation rate and C-reactive protein in ankylosing spondylitis: a literature review. J Rheumatol 26:966–970PubMed Ruof J, Stucki G (1999) Validity aspects of erythrocyte sedimentation rate and C-reactive protein in ankylosing spondylitis: a literature review. J Rheumatol 26:966–970PubMed
3.
Zurück zum Zitat Colglazier CL, Sutej PG (2005) Laboratory testing in the rheumatic diseases: a practical review. South Med J 98:185–191CrossRefPubMed Colglazier CL, Sutej PG (2005) Laboratory testing in the rheumatic diseases: a practical review. South Med J 98:185–191CrossRefPubMed
4.
Zurück zum Zitat Kavanaugh A (1999) The role of the laboratory in the evaluation of rheumatic diseases. Clin Cornerstone 2(2):11–25CrossRefPubMed Kavanaugh A (1999) The role of the laboratory in the evaluation of rheumatic diseases. Clin Cornerstone 2(2):11–25CrossRefPubMed
5.
Zurück zum Zitat Mercan R, Bitik B, Tufan A, Bozbulut UB, Atas N, Ozturk MA, Haznedaroglu S, Goker B (2015) The association between neutrophil/lymphocyte ratio and disease activity in rheumatoid arthritis and ankylosing spondylitis. J Clin Lab Anal. doi:10.1002/jcla.21908 (Epub ahead of print) PubMed Mercan R, Bitik B, Tufan A, Bozbulut UB, Atas N, Ozturk MA, Haznedaroglu S, Goker B (2015) The association between neutrophil/lymphocyte ratio and disease activity in rheumatoid arthritis and ankylosing spondylitis. J Clin Lab Anal. doi:10.​1002/​jcla.​21908 (Epub ahead of print) PubMed
6.
Zurück zum Zitat Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340(6):448–454CrossRefPubMed Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340(6):448–454CrossRefPubMed
7.
Zurück zum Zitat Zahorec R (2001) Ratio of neutrophil to lymphocyte counts. Rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy 102:5–14PubMed Zahorec R (2001) Ratio of neutrophil to lymphocyte counts. Rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy 102:5–14PubMed
8.
Zurück zum Zitat Gokmen F, Akbal A, Reşorlu H, Gökmen E, Güven M, Aras AB, Erbağ G, Kömürcü E, Akbal E, Coşar M (2014) Neutrophil-lymphocyte ratio connected to treatment options and inflammation markers of ankylosing spondylitis. J Clin Lab Anal 21:231–236 Gokmen F, Akbal A, Reşorlu H, Gökmen E, Güven M, Aras AB, Erbağ G, Kömürcü E, Akbal E, Coşar M (2014) Neutrophil-lymphocyte ratio connected to treatment options and inflammation markers of ankylosing spondylitis. J Clin Lab Anal 21:231–236
9.
Zurück zum Zitat Vayá A, Hernández V, Rivera L, Hernández JL, Lago A, España F, Bautista D (2014) Red blood cell distribution width in patients with cryptogenic stroke. Clin Appl Thromb Hemost 25:463–467 Vayá A, Hernández V, Rivera L, Hernández JL, Lago A, España F, Bautista D (2014) Red blood cell distribution width in patients with cryptogenic stroke. Clin Appl Thromb Hemost 25:463–467
10.
Zurück zum Zitat Wang P, Wang Y, Li H, Wu Y, Chen H (2014) Relationship between the red blood cell distributionwidth and risk of acute myocardial infarction. J Atheroscler Thromb 21:1–6CrossRef Wang P, Wang Y, Li H, Wu Y, Chen H (2014) Relationship between the red blood cell distributionwidth and risk of acute myocardial infarction. J Atheroscler Thromb 21:1–6CrossRef
11.
Zurück zum Zitat Peng YF, Zhang Q, Cao L, Liu Y, Chen D, Sun YK, Zhang ZX (2014) Red blood cell distribution width: a potential maker estimating disease activity of ankylosing spondylitis. Int J Clin Exp Med 7(12):5289–5295PubMedPubMedCentral Peng YF, Zhang Q, Cao L, Liu Y, Chen D, Sun YK, Zhang ZX (2014) Red blood cell distribution width: a potential maker estimating disease activity of ankylosing spondylitis. Int J Clin Exp Med 7(12):5289–5295PubMedPubMedCentral
12.
Zurück zum Zitat Briggs C (2009) Quality counts: new parameters in blood cell counting. Int J Lab Hematol 31:277–297CrossRefPubMed Briggs C (2009) Quality counts: new parameters in blood cell counting. Int J Lab Hematol 31:277–297CrossRefPubMed
13.
Zurück zum Zitat Kisacik B, Tufan A, Kalyoncu U, Karadag O, Akdogan A, Ozturk MA, Kiraz S, Ertenli I, Calguneri M (2008) Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis. Joint Bone Spine 75(3):291–294CrossRefPubMed Kisacik B, Tufan A, Kalyoncu U, Karadag O, Akdogan A, Ozturk MA, Kiraz S, Ertenli I, Calguneri M (2008) Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis. Joint Bone Spine 75(3):291–294CrossRefPubMed
14.
Zurück zum Zitat Resorlu H, Resorlu M, Gokmen F, Akbal A, Adam G, Komurcu E, Goksel F et al (2015) Association between mean platelet volume and bone mineral density in patients with ankylosing spondylitis and diagnostic value of diffusion-weighted magnetic resonance imaging. J Phys Ther Sci 27(4):1137–1140CrossRefPubMedPubMedCentral Resorlu H, Resorlu M, Gokmen F, Akbal A, Adam G, Komurcu E, Goksel F et al (2015) Association between mean platelet volume and bone mineral density in patients with ankylosing spondylitis and diagnostic value of diffusion-weighted magnetic resonance imaging. J Phys Ther Sci 27(4):1137–1140CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Alatas N, Yazgan P, Ozturk A, San I, Iynen I (2005) Audiological wndings in patients with ankylosing spondylitis. J Laryngol Otol 119(7):534–539CrossRefPubMed Alatas N, Yazgan P, Ozturk A, San I, Iynen I (2005) Audiological wndings in patients with ankylosing spondylitis. J Laryngol Otol 119(7):534–539CrossRefPubMed
17.
Zurück zum Zitat Casellini C, Citera G, RosemVet M, Ruggeri S, Saviotti A, Maldonado Cocco JA (2005) Audiovestibular disorders in patients with ankylosing spondylitis. J Clin Rheumatol 11(2):81–85CrossRefPubMed Casellini C, Citera G, RosemVet M, Ruggeri S, Saviotti A, Maldonado Cocco JA (2005) Audiovestibular disorders in patients with ankylosing spondylitis. J Clin Rheumatol 11(2):81–85CrossRefPubMed
19.
Zurück zum Zitat Corapci I, Armagan O, Tascioglu F, Oner C (2004) Sensorineural hearing loss in a patient with ankylosing spondylitis. Rheumatol Int 24(4):252–253CrossRefPubMed Corapci I, Armagan O, Tascioglu F, Oner C (2004) Sensorineural hearing loss in a patient with ankylosing spondylitis. Rheumatol Int 24(4):252–253CrossRefPubMed
20.
Zurück zum Zitat Raza K, Karokis D, Wilson F, Delamere JP (1998) Sensorineural hearing loss, iritis and ankylosing spondylitis. Br J Rheumatol 37(12):1363CrossRefPubMed Raza K, Karokis D, Wilson F, Delamere JP (1998) Sensorineural hearing loss, iritis and ankylosing spondylitis. Br J Rheumatol 37(12):1363CrossRefPubMed
21.
Zurück zum Zitat Erbek SS, Erbek HS, Yilmaz S, Topal O, Yucel E, Ozluoglu LN (2006) Cochleovestibular dysfunction in ankylosing spondylitis. Audiol Neurootol 11(5):294–300CrossRefPubMed Erbek SS, Erbek HS, Yilmaz S, Topal O, Yucel E, Ozluoglu LN (2006) Cochleovestibular dysfunction in ankylosing spondylitis. Audiol Neurootol 11(5):294–300CrossRefPubMed
22.
Zurück zum Zitat Adam M, Erkan AN, Arslan D, Leblebici B, Ozlüoğlu L, Nafiz Akman M (2008) High-frequency sensorineural hearing loss in patients with ankylosing spondylitis: is it an extra-articular feature of disease? Rheumatol Int 28(5):413–417CrossRefPubMed Adam M, Erkan AN, Arslan D, Leblebici B, Ozlüoğlu L, Nafiz Akman M (2008) High-frequency sensorineural hearing loss in patients with ankylosing spondylitis: is it an extra-articular feature of disease? Rheumatol Int 28(5):413–417CrossRefPubMed
23.
Zurück zum Zitat Gokmen F, Akbal A, Reşorlu H, Gökmen E, Güven M, Aras AB, Erbağ G, Kömürcü E, Akbal E, Coşar M (2015) Neutrophil-lymphocyte ratio connected to treatment options and inflammation markers of ankylosing spondylitis. J Clin Lab Anal 29(4):294–298CrossRefPubMed Gokmen F, Akbal A, Reşorlu H, Gökmen E, Güven M, Aras AB, Erbağ G, Kömürcü E, Akbal E, Coşar M (2015) Neutrophil-lymphocyte ratio connected to treatment options and inflammation markers of ankylosing spondylitis. J Clin Lab Anal 29(4):294–298CrossRefPubMed
24.
Zurück zum Zitat Garrett S, Jenkinson T, Kennedy LG et al (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286–2291PubMed Garrett S, Jenkinson T, Kennedy LG et al (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286–2291PubMed
25.
Zurück zum Zitat van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368CrossRefPubMed van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368CrossRefPubMed
26.
Zurück zum Zitat Van Der Linden S, Van Der Hiejde D, Braun J (2005) Spondyloarthropathies: ankylosing spondilitis. In: Harris ED (ed) Kelley’s textbook of rheumatology, vol 2, 7th edn. Elsevier, Philadelphia, pp 1125–1141 Van Der Linden S, Van Der Hiejde D, Braun J (2005) Spondyloarthropathies: ankylosing spondilitis. In: Harris ED (ed) Kelley’s textbook of rheumatology, vol 2, 7th edn. Elsevier, Philadelphia, pp 1125–1141
27.
Zurück zum Zitat van der Linden S, van der Heijde D (2000) Clinical aspects, outcome assessment, and management of ankylosing spondylitis and post enteric reactive arthritis. Curr Opin Rheumatol 12(4):263–268CrossRefPubMed van der Linden S, van der Heijde D (2000) Clinical aspects, outcome assessment, and management of ankylosing spondylitis and post enteric reactive arthritis. Curr Opin Rheumatol 12(4):263–268CrossRefPubMed
28.
Zurück zum Zitat Amor-Dorado JC, Barreira-Fernandez MP, Vazquez-Rodriguez TR et al (2011) Audiovestibular manifestations in patients with ankylosing spondylitis. Medicine (Baltimore) 90(2):99–109CrossRef Amor-Dorado JC, Barreira-Fernandez MP, Vazquez-Rodriguez TR et al (2011) Audiovestibular manifestations in patients with ankylosing spondylitis. Medicine (Baltimore) 90(2):99–109CrossRef
29.
Zurück zum Zitat Yeo SW, Park SN (2001) Immune-mediated sensorineural hearing loss in a patient with ankylosing spondylitis: a case report. Otolaryngol Head Neck Surg 125(1):113–114CrossRefPubMed Yeo SW, Park SN (2001) Immune-mediated sensorineural hearing loss in a patient with ankylosing spondylitis: a case report. Otolaryngol Head Neck Surg 125(1):113–114CrossRefPubMed
30.
Zurück zum Zitat Ajodhia JM, Dix MR (1976) Drug-induced deafness and its treatment. Practitioner 216(1295):561–570PubMed Ajodhia JM, Dix MR (1976) Drug-induced deafness and its treatment. Practitioner 216(1295):561–570PubMed
31.
Zurück zum Zitat Camilleri AE, Swan IR, Sturrock R (1991) Chronic otitis media and ankylosing spondylitis: an HLA association? Clin Otolaryngol Allied Sci 16(4):364–366CrossRefPubMed Camilleri AE, Swan IR, Sturrock R (1991) Chronic otitis media and ankylosing spondylitis: an HLA association? Clin Otolaryngol Allied Sci 16(4):364–366CrossRefPubMed
32.
Zurück zum Zitat Dornhoffer JL, Arenberg IK (1997) Immune mechanisms in Meniere’s syndrome. Otolaryngol Clin N Am 30:1017–1026 Dornhoffer JL, Arenberg IK (1997) Immune mechanisms in Meniere’s syndrome. Otolaryngol Clin N Am 30:1017–1026
33.
Zurück zum Zitat Ruckenstein MJ (2004) Autoimmune inner ear disease. Curr Opin Otolaryngol Head Neck Surg 2:426–430CrossRef Ruckenstein MJ (2004) Autoimmune inner ear disease. Curr Opin Otolaryngol Head Neck Surg 2:426–430CrossRef
34.
Zurück zum Zitat Gussen R (1977) Polyarteritis nodosa and deafness. A human temporal bone study. Arch Otorhinolaryngol 217:263–271CrossRefPubMed Gussen R (1977) Polyarteritis nodosa and deafness. A human temporal bone study. Arch Otorhinolaryngol 217:263–271CrossRefPubMed
35.
Zurück zum Zitat Quick CA, Fish A, Brown C (1973) The relationship between cochlea and kidney. Laryngoscope 83:1469–1482CrossRefPubMed Quick CA, Fish A, Brown C (1973) The relationship between cochlea and kidney. Laryngoscope 83:1469–1482CrossRefPubMed
36.
Zurück zum Zitat Quick CA (1975) Antigenic causes of hearing loss. Otolaryngol Clin North Am 8:385–394PubMed Quick CA (1975) Antigenic causes of hearing loss. Otolaryngol Clin North Am 8:385–394PubMed
37.
Zurück zum Zitat Harris JP (1983) Immunology of the inner ear. Response of the inner ear to antigen challenge. Otolaryngol Head Neck Surg 91:18–23CrossRefPubMed Harris JP (1983) Immunology of the inner ear. Response of the inner ear to antigen challenge. Otolaryngol Head Neck Surg 91:18–23CrossRefPubMed
38.
Zurück zum Zitat Mogi G, Kawauchi H, Suruki M, Sato N (1985) Inner ear immunology. Am J Otolaryngol 6:142–147CrossRefPubMed Mogi G, Kawauchi H, Suruki M, Sato N (1985) Inner ear immunology. Am J Otolaryngol 6:142–147CrossRefPubMed
39.
Zurück zum Zitat Harris JP (1984) Immunology of the inner ear. Evidence of local antibody production. Ann Otol Rhinol 3:157–162CrossRef Harris JP (1984) Immunology of the inner ear. Evidence of local antibody production. Ann Otol Rhinol 3:157–162CrossRef
40.
Zurück zum Zitat Eryilmaz A, Dagli M, Karabulut H, Sivas Acar F et al (2007) Evaluation of hearing loss in patients with ankylosing spondylitis. J Laryngol Otol 121:845–849CrossRefPubMed Eryilmaz A, Dagli M, Karabulut H, Sivas Acar F et al (2007) Evaluation of hearing loss in patients with ankylosing spondylitis. J Laryngol Otol 121:845–849CrossRefPubMed
41.
Zurück zum Zitat Dagli M, Sivas Acar F, Karabulut H, Eryilmaz A, Erkol Inal E (2007) Evaluation of hearing and cochlear function by DPOAE and audiometric tests in patients with ankylosing spondilitis. Rheumatol Int 27:511–516CrossRefPubMed Dagli M, Sivas Acar F, Karabulut H, Eryilmaz A, Erkol Inal E (2007) Evaluation of hearing and cochlear function by DPOAE and audiometric tests in patients with ankylosing spondilitis. Rheumatol Int 27:511–516CrossRefPubMed
42.
Zurück zum Zitat Savastano M, Marioni G, Bernini G, Punzi L (2005) Tinnitus and bilateral sensorineural hearing loss: ankylosing spondylitis or a side effect of sulphasalazine treatment? Acta Otolaryngol 125(6):671–673CrossRefPubMed Savastano M, Marioni G, Bernini G, Punzi L (2005) Tinnitus and bilateral sensorineural hearing loss: ankylosing spondylitis or a side effect of sulphasalazine treatment? Acta Otolaryngol 125(6):671–673CrossRefPubMed
43.
Zurück zum Zitat Kahveci OK, Demirdal US, Duran A, Altuntas A, Kavuncu V, Okur E (2012) Hearing and cochlear function of patients with ankylosing spondylitis. Clin Rheumatol 31(7):1103–1108CrossRefPubMed Kahveci OK, Demirdal US, Duran A, Altuntas A, Kavuncu V, Okur E (2012) Hearing and cochlear function of patients with ankylosing spondylitis. Clin Rheumatol 31(7):1103–1108CrossRefPubMed
44.
Zurück zum Zitat Xu L, Pfaltz CR, Arnold W (1993) Human leukocyte antigens in patients with inner ear diseases of unknown etiology. ORL J Otorhinolaryngol Relat Spec 55(3):125–134CrossRefPubMed Xu L, Pfaltz CR, Arnold W (1993) Human leukocyte antigens in patients with inner ear diseases of unknown etiology. ORL J Otorhinolaryngol Relat Spec 55(3):125–134CrossRefPubMed
45.
Zurück zum Zitat Bar-Eli M, Ehrenfeld M, Levy M, Gallily R, Eliakim M (1981) Leukocyte chemotaxis in recurrent polyserositis (familial Mediterranean fever). Am J Med Sci 281:15–18CrossRefPubMed Bar-Eli M, Ehrenfeld M, Levy M, Gallily R, Eliakim M (1981) Leukocyte chemotaxis in recurrent polyserositis (familial Mediterranean fever). Am J Med Sci 281:15–18CrossRefPubMed
46.
Zurück zum Zitat Otterness IG (1994) The value of C-reactive protein measurement in rheumatoid arthritis. Semin Arthritis Rheum 24:91–104CrossRefPubMed Otterness IG (1994) The value of C-reactive protein measurement in rheumatoid arthritis. Semin Arthritis Rheum 24:91–104CrossRefPubMed
47.
Zurück zum Zitat Spoorenberg A, van der Heijde D, de Klerk E et al (1999) Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol 26:980–984PubMed Spoorenberg A, van der Heijde D, de Klerk E et al (1999) Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol 26:980–984PubMed
48.
Zurück zum Zitat Cansu DU, Calısır C, Savas Yavas U, Kasifoğlu T, Korkmaz C (2011) Predictors of radiographic severity and functional disability in Turkish patients with ankylosing spondylitis. Clin Rheumatol 30:557–562CrossRefPubMed Cansu DU, Calısır C, Savas Yavas U, Kasifoğlu T, Korkmaz C (2011) Predictors of radiographic severity and functional disability in Turkish patients with ankylosing spondylitis. Clin Rheumatol 30:557–562CrossRefPubMed
49.
Zurück zum Zitat Doran MF, Brophy S, MacKay K, Taylor G, Calin A (2003) Predictors of longterm outcome in ankylosing spondylitis. J Rheumatol 30:316–320PubMed Doran MF, Brophy S, MacKay K, Taylor G, Calin A (2003) Predictors of longterm outcome in ankylosing spondylitis. J Rheumatol 30:316–320PubMed
50.
Zurück zum Zitat Papa A, Emdin M, Passino C, Michelassi C, Battaglia D, Cocci F (2008) Predictive value of elevated neutrophil–lymphocyte ratio on cardiac mortality in patients with stable coronary artery disease. Clin Chim Acta 395(1–2):27–31CrossRefPubMed Papa A, Emdin M, Passino C, Michelassi C, Battaglia D, Cocci F (2008) Predictive value of elevated neutrophil–lymphocyte ratio on cardiac mortality in patients with stable coronary artery disease. Clin Chim Acta 395(1–2):27–31CrossRefPubMed
51.
Zurück zum Zitat Arruda-Olson AM, Reeder GS, Bell MR et al (2009) Neutrophilia predicts death and heart failure after myocardial infarction: a community-based study. Circ Cardiovasc Qual Outcomes 2:656–662CrossRefPubMedPubMedCentral Arruda-Olson AM, Reeder GS, Bell MR et al (2009) Neutrophilia predicts death and heart failure after myocardial infarction: a community-based study. Circ Cardiovasc Qual Outcomes 2:656–662CrossRefPubMedPubMedCentral
52.
Zurück zum Zitat Rudiger A, Burckhardt OA, Harpes P et al (2006) The relative lymphocyte count on hospital admission is a risk factor for long-term mortality in patients with acute heart failure. Am J Emerg Med 24:451–454CrossRefPubMed Rudiger A, Burckhardt OA, Harpes P et al (2006) The relative lymphocyte count on hospital admission is a risk factor for long-term mortality in patients with acute heart failure. Am J Emerg Med 24:451–454CrossRefPubMed
53.
Zurück zum Zitat Demirkol S, Balta S, Unlu M et al (2014) Neutrophils/lymphocytes ratio in patients with cardiac syndrome X and its association with carotid intima-media thickness. Clin Appl Thromb Hemost 20:250–255CrossRefPubMed Demirkol S, Balta S, Unlu M et al (2014) Neutrophils/lymphocytes ratio in patients with cardiac syndrome X and its association with carotid intima-media thickness. Clin Appl Thromb Hemost 20:250–255CrossRefPubMed
54.
Zurück zum Zitat Gillum RF, Mussolino ME, Madans JH (2005) Counts of neutrophils, lymphocytes, and monocytes, cause-specific mortality and coronary heart disease: the NHANES-I epidemiologic follow-up study. Ann Epidemiol 15(4):266–271CrossRefPubMed Gillum RF, Mussolino ME, Madans JH (2005) Counts of neutrophils, lymphocytes, and monocytes, cause-specific mortality and coronary heart disease: the NHANES-I epidemiologic follow-up study. Ann Epidemiol 15(4):266–271CrossRefPubMed
55.
Zurück zum Zitat Ahsen A, Ulu MS, Yuksel S et al (2013) As a new inflammatory marker for familial Mediterranean fever: neutrophil-to-lymphocyte ratio. Inflammation 36:1357–1362CrossRefPubMed Ahsen A, Ulu MS, Yuksel S et al (2013) As a new inflammatory marker for familial Mediterranean fever: neutrophil-to-lymphocyte ratio. Inflammation 36:1357–1362CrossRefPubMed
56.
Zurück zum Zitat Uslu AU, Deveci K, Korkmaz S et al (2013) Is neutrophil/lymphocyte ratio associated with subclinical inflammation and amyloidosis in patients with familial Mediterranean fever? Biomed Res Int 2013:185317CrossRefPubMedPubMedCentral Uslu AU, Deveci K, Korkmaz S et al (2013) Is neutrophil/lymphocyte ratio associated with subclinical inflammation and amyloidosis in patients with familial Mediterranean fever? Biomed Res Int 2013:185317CrossRefPubMedPubMedCentral
57.
Zurück zum Zitat Wei JC, Hung KS, Hsu YW, Wong RH, Huang CH, Jan MS, Wu SJ, Juan YS, Chang WC (2012) Genetic polymorphisms of stromal interaction molecule associated with the erythrocyte sedimentation rate and C-reactive protein in HLAB27 positive ankylosing spondylitis patients. PLoS One 7:1–6 Wei JC, Hung KS, Hsu YW, Wong RH, Huang CH, Jan MS, Wu SJ, Juan YS, Chang WC (2012) Genetic polymorphisms of stromal interaction molecule associated with the erythrocyte sedimentation rate and C-reactive protein in HLAB27 positive ankylosing spondylitis patients. PLoS One 7:1–6
58.
Zurück zum Zitat Kaplan ZS, Jackson SP (2011) The role of platelets in atherothrombosis. Hematol Am Soc Hematol Educ Progr 2011:51–61 Kaplan ZS, Jackson SP (2011) The role of platelets in atherothrombosis. Hematol Am Soc Hematol Educ Progr 2011:51–61
59.
Zurück zum Zitat Park Y, Schoene N, Harris W (2002) Mean platelet volume as an indicator of platelet activation: methodological issues. Platelets 13:301–306CrossRefPubMed Park Y, Schoene N, Harris W (2002) Mean platelet volume as an indicator of platelet activation: methodological issues. Platelets 13:301–306CrossRefPubMed
60.
Zurück zum Zitat Yazici S, Yazici M, Erer B et al (2010) The platelet indices in patients with rheumatoid arthritis: mean platelet volume reflects disease activity. Platelets 21:122–125CrossRefPubMed Yazici S, Yazici M, Erer B et al (2010) The platelet indices in patients with rheumatoid arthritis: mean platelet volume reflects disease activity. Platelets 21:122–125CrossRefPubMed
61.
Zurück zum Zitat Bath PM, Butterworth RJ (1996) Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis 7:157–161CrossRefPubMed Bath PM, Butterworth RJ (1996) Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis 7:157–161CrossRefPubMed
62.
Zurück zum Zitat Kapsoritakis AN, Koukourakis MI, Sfiridaki A et al (2001) Mean platelet volume: a useful marker of inflammatory bowel disease activity. Am J Gastroenterol 96:776–781CrossRefPubMed Kapsoritakis AN, Koukourakis MI, Sfiridaki A et al (2001) Mean platelet volume: a useful marker of inflammatory bowel disease activity. Am J Gastroenterol 96:776–781CrossRefPubMed
63.
Zurück zum Zitat Ertenli I, Kiraz S, Ozturk MA et al (2003) Pathologic thrombopoiesis of rheumatoid arthritis. Rheumatol Int 23:49–60PubMed Ertenli I, Kiraz S, Ozturk MA et al (2003) Pathologic thrombopoiesis of rheumatoid arthritis. Rheumatol Int 23:49–60PubMed
64.
Zurück zum Zitat Endler G, Klimesch A, Sunder-Plassmann H et al (2002) Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol 117:399–404CrossRefPubMed Endler G, Klimesch A, Sunder-Plassmann H et al (2002) Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol 117:399–404CrossRefPubMed
65.
Zurück zum Zitat Song CS, Park DI, Yoon MY, Seok HS, Park JH, Kim HJ (2012) Association between red cell distribution width and disease activity in patients with inflammatory bowel disease. Dig Dis Sci 57:1033–1038CrossRefPubMed Song CS, Park DI, Yoon MY, Seok HS, Park JH, Kim HJ (2012) Association between red cell distribution width and disease activity in patients with inflammatory bowel disease. Dig Dis Sci 57:1033–1038CrossRefPubMed
66.
Zurück zum Zitat Lippi G, Targher G, Montagnana M, Salvagno GL, Zoppini G, Guidi GC (2009) Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Arch Pathol Lab Med 133:628–632PubMed Lippi G, Targher G, Montagnana M, Salvagno GL, Zoppini G, Guidi GC (2009) Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Arch Pathol Lab Med 133:628–632PubMed
67.
Zurück zum Zitat Ku NS, Kim HW, Oh HJ, Kim YC, Kim MH, Song JE, Oh DH (2012) Red blood cell distribution width is an independent predictor of mortalityin patients with gram negative bacteremia. Shock 38:123–127CrossRefPubMed Ku NS, Kim HW, Oh HJ, Kim YC, Kim MH, Song JE, Oh DH (2012) Red blood cell distribution width is an independent predictor of mortalityin patients with gram negative bacteremia. Shock 38:123–127CrossRefPubMed
69.
Zurück zum Zitat Freeman RB, Wiesner RH, Harper A, McDiarmid SV, Lake J (2002) The new liver allocation system: moving toward evidence-based transplantationpolicy. Liver Transpl 8:851–858CrossRefPubMed Freeman RB, Wiesner RH, Harper A, McDiarmid SV, Lake J (2002) The new liver allocation system: moving toward evidence-based transplantationpolicy. Liver Transpl 8:851–858CrossRefPubMed
Metadaten
Titel
Mean platelet volume, red cell distribution width, platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios in patients with ankylosing spondylitis and their relationships with high-frequency hearing thresholds
verfasst von
Nazim Bozan
Mahmut Alpaycı
Mehmet Aslan
Hakan Cankaya
Ahmet Faruk Kıroglu
Mahfuz Turan
Abdurrahman Ayral
Emre Senkoy
Server Ilter
Publikationsdatum
31.03.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Oto-Rhino-Laryngology / Ausgabe 11/2016
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-016-3980-y

Weitere Artikel der Ausgabe 11/2016

European Archives of Oto-Rhino-Laryngology 11/2016 Zur Ausgabe

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.